{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:30:11Z","timestamp":1789446611595,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019693","name":"Universidade Federal Da Fronteira Sul","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019693","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chronic kidney disease (CKD) affects approximately 13.4% of the global population and significantly impacts patients\u2019 quality of life. This study aimed to investigate the effects of resistance exercise on blood pressure and purinergic signaling in patients with CKD. Here, 28 patients with CKD performed a 12-week resistance exercise protocol during hemodialysis. Blood samples were collected before and after the intervention. Biochemical analyses, for example, NTPDases, ecto-5\u2032-nucleotidase, and adenosine deaminase, were measured in platelets. Flow cytometry was performed to investigate CD39 and CD73 expression on lymphocytes. In addition, extracellular ATP and blood pressure were analyzed. Our findings revealed that patients with CKD present high systolic blood pressure (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0002) compared to control, and resistance exercise reduces blood pressure in these patients (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.007). Regarding purinergic signaling, an increase in NTPDases, ecto-5\u2032-nucleotidase, and adenosine deaminase was observed in patients with CKD (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0007, respectively). Surprisingly, after resistance exercise, NTPDase\/ATP and ecto-5\u2032-nucleotidase decreased (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0006;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.02). CD39 and CD73 expression significantly increased on lymphocytes of CKD patients compared to control (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.004;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0002, respectively). After resistance exercise, CD39 and CD73 expression was downregulated. Extracellular ATP levels were decreased in CKD (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001), and resistance exercise restored these levels. In conclusion, CKD patients present high activity and expression of CD39 and CD73 enzymes, and resistance exercise mitigated purinergic exacerbation and presents anti-hypertensive effects in patients with CKD.\n                  <\/jats:p>","DOI":"10.1007\/s11302-025-10121-7","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:43:19Z","timestamp":1769031799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Resistance exercise exerts anti-hypertensive effects and downregulates NTPDase\/CD39 and ecto-5\u2032-nucleotidase\/CD73 expression in patients with chronic kidney disease undergoing hemodialysis"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3779-0419","authenticated-orcid":false,"given":"Angela Makeli Kososki","family":"Dalagnol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-0466","authenticated-orcid":false,"given":"Francini","family":"Franscescon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-775X","authenticated-orcid":false,"given":"Matheus Chimelo","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1607-6571","authenticated-orcid":false,"given":"Josiano Guilherme","family":"Puhle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5737-057X","authenticated-orcid":false,"given":"Keroli Eloiza Tessaro","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-9418","authenticated-orcid":false,"given":"Helam\u00e3 Moraes","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5746-7109","authenticated-orcid":false,"given":"Sarah Franco Vieira","family":"de Oliveira Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3813-7139","authenticated-orcid":false,"given":"D\u00e9bora Tavares","family":"de Resende e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"10121_CR1","doi-asserted-by":"publisher","DOI":"10.7326\/AITC201506020","volume":"162","author":"P Drawz","year":"2015","unstructured":"Drawz P, Rahman M (2015) Chronic kidney disease. Ann Intern Med 162:ITC1-16. https:\/\/doi.org\/10.7326\/AITC201506020","journal-title":"Ann Intern Med"},{"key":"10121_CR2","doi-asserted-by":"publisher","first-page":"e200044","DOI":"10.1590\/1980-549720200044","volume":"23","author":"LK de Aguiar","year":"2020","unstructured":"de Aguiar LK, Prado RR, Gazzinelli A, Malta DC (2020) Factors associated with chronic kidney disease: epidemiological survey of the National Health Survey. Rev Bras Epidemiol 23:e200044. https:\/\/doi.org\/10.1590\/1980-549720200044","journal-title":"Rev Bras Epidemiol"},{"key":"10121_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12325-021-01927-z","volume":"39","author":"M Evans","year":"2022","unstructured":"Evans M, Lewis RD, Morgan AR et al (2022) A narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv Ther 39:33\u201343. https:\/\/doi.org\/10.1007\/s12325-021-01927-z","journal-title":"Adv Ther"},{"key":"10121_CR4","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389:1238\u20131252. https:\/\/doi.org\/10.1016\/S0140-6736(16)32064-5","journal-title":"Lancet"},{"key":"10121_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bcmd.2005.12.025","volume":"36","author":"B Atkinson","year":"2006","unstructured":"Atkinson B, Dwyer K, Enjyoji K, Robson SC (2006) Ecto-nucleotidases of the CD39\/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells Mol Dis 36:217\u2013222. https:\/\/doi.org\/10.1016\/j.bcmd.2005.12.025","journal-title":"Blood Cells Mol Dis"},{"key":"10121_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11302-021-09807-5","volume":"17","author":"Z Zhou","year":"2021","unstructured":"Zhou Z (2021) Purinergic interplay between erythrocytes and platelets in diabetes-associated vascular dysfunction. Purinergic Signal 17:705\u2013712. https:\/\/doi.org\/10.1007\/s11302-021-09807-5","journal-title":"Purinergic Signal"},{"key":"10121_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11302-005-5302-5","volume":"2","author":"SP Colgan","year":"2006","unstructured":"Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5\u2019-nucleotidase (CD73). Purinergic Signal 2:351\u2013360. https:\/\/doi.org\/10.1007\/s11302-005-5302-5","journal-title":"Purinergic Signal"},{"key":"10121_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11302-011-9247-6","volume":"7","author":"B Hechler","year":"2011","unstructured":"Hechler B, Gachet C (2011) P2 receptors and platelet function. Purinergic Signal 7:293\u2013303. https:\/\/doi.org\/10.1007\/s11302-011-9247-6","journal-title":"Purinergic Signal"},{"key":"10121_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG (2008) Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783:673\u2013694. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.01.024","journal-title":"Biochim Biophys Acta"},{"key":"10121_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11302-021-09839-x","volume":"19","author":"X-M Wu","year":"2023","unstructured":"Wu X-M, Zhang N, Li J-S et al (2023) Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis. Purinergic Signal 19:265\u2013272. https:\/\/doi.org\/10.1007\/s11302-021-09839-x","journal-title":"Purinergic Signal"},{"key":"10121_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s11332-022-00970-9","volume":"19","author":"MR Bizuti","year":"2023","unstructured":"Bizuti MR, de Camargo SE, Haag FB et al (2023) Concurrent training is able to increase the activity of adenosine deaminase in platelets in young women. Sport Sci Health 19:849\u2013859. https:\/\/doi.org\/10.1007\/s11332-022-00970-9","journal-title":"Sport Sci Health"},{"key":"10121_CR12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1097\/HJH.0000000000003529","volume":"41","author":"AM Cardoso","year":"2023","unstructured":"Cardoso AM, Aneli NM, Lammers M et al (2023) Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling. J Hypertens 41:1745\u20131752. https:\/\/doi.org\/10.1097\/HJH.0000000000003529","journal-title":"J Hypertens"},{"key":"10121_CR13","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00467-018-4005-4","volume":"34","author":"K Daenen","year":"2019","unstructured":"Daenen K, Andries A, Mekahli D et al (2019) Oxidative stress in chronic kidney disease. Pediatr Nephrol 34:975\u2013991. https:\/\/doi.org\/10.1007\/s00467-018-4005-4","journal-title":"Pediatr Nephrol"},{"key":"10121_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11302-023-09950-1","volume":"20","author":"E de Resende","year":"2024","unstructured":"de Resende E, Silva DT, Bizuti MR, de Oliveira NR et al (2024) Physical exercise as a modulator of the purinergic system in the control of sarcopenia in individuals with chronic kidney disease on hemodialysis. Purinergic Signal 20:213\u2013222. https:\/\/doi.org\/10.1007\/s11302-023-09950-1","journal-title":"Purinergic Signal"},{"key":"10121_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11332-025-01380-3","author":"D de Cristo","year":"2025","unstructured":"de Cristo D, Dalagnol AMK, Puhle JG et al (2025) Physical exercise as a modulator of ectonucleotidases activity in lymphocytes and cytokine levels in individuals on hemodialysis. Sport Sci Health. https:\/\/doi.org\/10.1007\/s11332-025-01380-3","journal-title":"Sport Sci Health"},{"key":"10121_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110399","volume":"111","author":"F Franscescon","year":"2021","unstructured":"Franscescon F, Souza TP, M\u00fcller TE et al (2021) Taurine prevents MK-801-induced shoal dispersion and altered cortisol responses in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry 111:110399. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110399","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10121_CR17","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40620-020-00840-y","volume":"34","author":"A Sabatino","year":"2021","unstructured":"Sabatino A, Cuppari L, Stenvinkel P et al (2021) Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol 34:1347\u20131372. https:\/\/doi.org\/10.1007\/s40620-020-00840-y","journal-title":"J Nephrol"},{"key":"10121_CR18","first-page":"87","volume":"44","author":"T Paillard","year":"2004","unstructured":"Paillard T, Lafont C, Soulat JM et al (2004) Neuromuscular effects of three training methods in ageing women. J Sports Med Phys Fitness 44:87\u201391","journal-title":"J Sports Med Phys Fitness"},{"key":"10121_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00069","volume":"6","author":"K Pinckard","year":"2019","unstructured":"Pinckard K, Baskin KK, Stanford KI (2019) Effects of exercise to improve cardiovascular health. Front Cardiovasc Med 6:69. https:\/\/doi.org\/10.3389\/fcvm.2019.00069","journal-title":"Front Cardiovasc Med"},{"key":"10121_CR20","doi-asserted-by":"publisher","unstructured":"Sociedade Brasileira de Cardiologia (2010) III Guidelines of Sociedade Brasileira de Cardiologia on the exercise test. Arq Bras Cardiol 95:1\u201326. https:\/\/doi.org\/10.1590\/S0066-782X2010000800001","DOI":"10.1590\/S0066-782X2010000800001"},{"key":"10121_CR21","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/sms.12714","volume":"26","author":"TJ Wilkinson","year":"2016","unstructured":"Wilkinson TJ, Shur NF, Smith AC (2016) \u201cExercise as medicine\u201d in chronic kidney disease. Scand J Med Sci Sports 26:985\u2013988. https:\/\/doi.org\/10.1111\/sms.12714","journal-title":"Scand J Med Sci Sports"},{"key":"10121_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.47626\/2237-6089-2021-0237","volume":"43","author":"FB Schuch","year":"2021","unstructured":"Schuch FB, Vancampfort D (2021) Physical activity, exercise, and mental disorders: it is time to move on. Trends Psychiatry Psychother 43:177\u2013184. https:\/\/doi.org\/10.47626\/2237-6089-2021-0237","journal-title":"Trends Psychiatry Psychother"},{"key":"10121_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05128-4","author":"F Franscescon","year":"2024","unstructured":"Franscescon F, Bianchini MC, Gheller E et al (2024) Resistance physical exercise modulates metabolic adipokines, decreases body weight, and improves glomerular filtration in patients with chronic kidney disease in hemodialysis. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-024-05128-4","journal-title":"Mol Cell Biochem"},{"key":"10121_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/09537109609023582","volume":"7","author":"C Pilla","year":"1996","unstructured":"Pilla C, Emanuelli T, Frassetto SS et al (1996) ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 7:225\u2013230. https:\/\/doi.org\/10.3109\/09537109609023582","journal-title":"Platelets"},{"key":"10121_CR25","first-page":"1312","volume":"42","author":"G Giusti","year":"1966","unstructured":"Giusti G, Galanti B (1966) Rapid colorimetric method for determination of some deaminase activities. Boll Soc Ital Biol Sper 42:1312\u20131316","journal-title":"Boll Soc Ital Biol Sper"},{"key":"10121_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00109-022-02185-4","volume":"100","author":"GB da Silva","year":"2022","unstructured":"da Silva GB, Manica D, da Silva AP et al (2022) High levels of extracellular ATP lead to different inflammatory responses in COVID-19 patients according to the severity. J Mol Med (Berl) 100:645\u2013663. https:\/\/doi.org\/10.1007\/s00109-022-02185-4","journal-title":"J Mol Med (Berl)"},{"key":"10121_CR27","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D et al (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143:1157\u20131172. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"key":"10121_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"key":"10121_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/metabo13070795","volume":"13","author":"VM Bai\u00e3o","year":"2023","unstructured":"Bai\u00e3o VM, Cunha VA, Duarte MP et al (2023) Effects of exercise on inflammatory markers in individuals with chronic kidney disease: a systematic review and meta-analysis. Metabolites 13:795. https:\/\/doi.org\/10.3390\/metabo13070795","journal-title":"Metabolites"},{"key":"10121_CR30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2215\/CJN.03670807","volume":"3","author":"P Stenvinkel","year":"2008","unstructured":"Stenvinkel P, Carrero JJ, Axelsson J et al (2008) Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3:505\u2013521. https:\/\/doi.org\/10.2215\/CJN.03670807","journal-title":"Clin J Am Soc Nephrol"},{"key":"10121_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1681\/ASN.2007080854","volume":"19","author":"SM Moe","year":"2008","unstructured":"Moe SM, Chen NX (2008) Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 19:213\u2013216. https:\/\/doi.org\/10.1681\/ASN.2007080854","journal-title":"J Am Soc Nephrol"},{"key":"10121_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","volume":"90","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND (2016) Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 90:41\u201352. https:\/\/doi.org\/10.1016\/j.kint.2016.02.026","journal-title":"Kidney Int"},{"key":"10121_CR33","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1681\/ASN.2006121329","volume":"18","author":"B Cheema","year":"2007","unstructured":"Cheema B, Abas H, Smith B et al (2007) Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. J Am Soc Nephrol 18:1594\u20131601. https:\/\/doi.org\/10.1681\/ASN.2006121329","journal-title":"J Am Soc Nephrol"},{"key":"10121_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","volume":"2","author":"SC Robson","year":"2006","unstructured":"Robson SC, S\u00e9vigny J, Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2:409\u2013430. https:\/\/doi.org\/10.1007\/s11302-006-9003-5","journal-title":"Purinergic Signal"},{"key":"10121_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4274\/jcrpe.v3i2.17","volume":"3","author":"B Y\u00fcksel","year":"2011","unstructured":"Y\u00fcksel B, \u00d6zbek MN, Mungan N\u00d6 et al (2011) Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6 years of age. J Clin Res Pediatr Endocrinol 3:84\u201388. https:\/\/doi.org\/10.4274\/jcrpe.v3i2.17","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10121_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells9091970","volume":"9","author":"T Yoshida","year":"2020","unstructured":"Yoshida T, Delafontaine P (2020) Mechanisms of IGF-1-mediated regulation of skeletal muscle hypertrophy and atrophy. Cells 9:1970. https:\/\/doi.org\/10.3390\/cells9091970","journal-title":"Cells"},{"key":"10121_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fphar.2013.00055","volume":"4","author":"L-H Jiang","year":"2013","unstructured":"Jiang L-H, Baldwin JM, Roger S, Baldwin SA (2013) Insights into the molecular mechanisms underlying mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms. Front Pharmacol 4:55. https:\/\/doi.org\/10.3389\/fphar.2013.00055","journal-title":"Front Pharmacol"},{"key":"10121_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-018-0026-y","volume":"54","author":"RS Nageeb","year":"2018","unstructured":"Nageeb RS, Hashim NA, Fawzy A (2018) Serum insulin-like growth factor 1 (IGF-1) in multiple sclerosis: relation to cognitive impairment and fatigue. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 54:25. https:\/\/doi.org\/10.1186\/s41983-018-0026-y","journal-title":"The Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"key":"10121_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1396938","author":"X Qiao","year":"2024","unstructured":"Qiao X, Yan J, Zang Z et al (2024) Association between IGF-1 levels and MDD: a case-control and meta-analysis. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2024.1396938","journal-title":"Front Psychiatry"},{"key":"10121_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/836486","volume":"2013","author":"M Gironi","year":"2013","unstructured":"Gironi M, Solaro C, Meazza C et al (2013) Growth hormone and disease severity in early stage of multiple sclerosis. Mult Scler Int 2013:836486. https:\/\/doi.org\/10.1155\/2013\/836486","journal-title":"Mult Scler Int"},{"key":"10121_CR41","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1212\/WNL.50.3.772","volume":"50","author":"I Torres-Aleman","year":"1998","unstructured":"Torres-Aleman I, Barrios V, Berciano J (1998) The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis. Neurology 50:772\u2013776. https:\/\/doi.org\/10.1212\/WNL.50.3.772","journal-title":"Neurology"},{"key":"10121_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297091","volume":"19","author":"S Yaghoobpoor","year":"2024","unstructured":"Yaghoobpoor S, Fathi M, Vakili K et al (2024) Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: a systematic review and meta-analysis. PLoS ONE 19:e0297091. https:\/\/doi.org\/10.1371\/journal.pone.0297091","journal-title":"PLoS ONE"},{"key":"10121_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-physiol-012422-112116","volume":"85","author":"S-J Lee","year":"2023","unstructured":"Lee S-J (2023) Myostatin: a skeletal muscle chalone. Annu Rev Physiol 85:269\u2013291. https:\/\/doi.org\/10.1146\/annurev-physiol-012422-112116","journal-title":"Annu Rev Physiol"},{"key":"10121_CR44","unstructured":"WHO (2020) WHO guidelines on physical activity and sedentary behaviour. https:\/\/www.who.int\/publications\/i\/item\/9789240015128. Accessed 1 Apr 2025"},{"key":"10121_CR45","doi-asserted-by":"publisher","first-page":"23068","DOI":"10.1038\/s41598-025-07378-8","volume":"15","author":"W Li","year":"2025","unstructured":"Li W, Yin R, Xia X et al (2025) Correlations of serum myostatin and irisin with sarcopenia and osteoporosis in rheumatoid arthritis patients: a cross-sectional study. Sci Rep 15:23068. https:\/\/doi.org\/10.1038\/s41598-025-07378-8","journal-title":"Sci Rep"},{"key":"10121_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/RHU.0000000000001806","volume":"28","author":"CM de Sordi","year":"2022","unstructured":"de Sordi CM, dos Reis-Neto ET, Keppeke GD et al (2022) Serum myostatin and follistatin levels in patients with dermatomyositis and polymyositis. JCR: Journal of Clinical Rheumatology 28:33. https:\/\/doi.org\/10.1097\/RHU.0000000000001806","journal-title":"JCR: Journal of Clinical Rheumatology"},{"key":"10121_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.rmed.2011.07.016","volume":"106","author":"C-R Ju","year":"2012","unstructured":"Ju C-R, Chen R-C (2012) Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease. Respir Med 106:102\u2013108. https:\/\/doi.org\/10.1016\/j.rmed.2011.07.016","journal-title":"Respir Med"},{"key":"10121_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080454","volume":"8","author":"A Breitbart","year":"2013","unstructured":"Breitbart A, Scharf GM, Duncker D et al (2013) Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients. PLoS ONE 8:e80454. https:\/\/doi.org\/10.1371\/journal.pone.0080454","journal-title":"PLoS ONE"},{"key":"10121_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/japplphysiol.01264.2001","volume":"93","author":"GR Adams","year":"2002","unstructured":"Adams GR (2002) Invited review: autocrine\/paracrine IGF-I and skeletal muscle adaptation. J Appl Physiol 93:1159\u20131167. https:\/\/doi.org\/10.1152\/japplphysiol.01264.2001","journal-title":"J Appl Physiol"},{"key":"10121_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092804","volume":"19","author":"N Ito","year":"2018","unstructured":"Ito N, Ruegg UT, Takeda S (2018) ATP-induced increase in intracellular calcium levels and subsequent activation of mTOR as regulators of skeletal muscle hypertrophy. Int J Mol Sci 19:2804. https:\/\/doi.org\/10.3390\/ijms19092804","journal-title":"Int J Mol Sci"},{"key":"10121_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamacardio.2021.2735","volume":"6","author":"S Lopes","year":"2021","unstructured":"Lopes S, Mesquita-Bastos J, Garcia C et al (2021) Effect of exercise training on ambulatory blood pressure among patients with resistant hypertension. JAMA Cardiol 6:1\u20137. https:\/\/doi.org\/10.1001\/jamacardio.2021.2735","journal-title":"JAMA Cardiol"},{"key":"10121_CR52","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jch.13804","volume":"22","author":"J Gambardella","year":"2020","unstructured":"Gambardella J, Morelli MB, Wang X, Santulli G (2020) Pathophysiological mechanisms underlying the beneficial effects of physical activity in hypertension. J Clin Hypertens (Greenwich) 22:291\u2013295. https:\/\/doi.org\/10.1111\/jch.13804","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10121_CR53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41371-023-00872-4","volume":"38","author":"B Baffour-Awuah","year":"2024","unstructured":"Baffour-Awuah B, Man M, Goessler KF et al (2024) Effect of exercise training on the renin\u2013angiotensin\u2013aldosterone system: a meta\u2013analysis. J Hum Hypertens 38:89\u2013101. https:\/\/doi.org\/10.1038\/s41371-023-00872-4","journal-title":"J Hum Hypertens"},{"key":"10121_CR54","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11302-021-09816-4","volume":"17","author":"AM Cardoso","year":"2021","unstructured":"Cardoso AM, Silv\u00e9rio MNO, de Oliveira Maciel SFV (2021) Purinergic signaling as a new mechanism underlying physical exercise benefits: a narrative review. Purinergic Signal 17:649\u2013679. https:\/\/doi.org\/10.1007\/s11302-021-09816-4","journal-title":"Purinergic Signal"},{"key":"10121_CR55","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/12447","volume":"5","author":"K Enjyoji","year":"1999","unstructured":"Enjyoji K, S\u00e9vigny J, Lin Y et al (1999) Targeted disruption of CD39\/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010\u20131017. https:\/\/doi.org\/10.1038\/12447","journal-title":"Nat Med"},{"key":"10121_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/biof.5520310205","volume":"31","author":"MRC Schetinger","year":"2007","unstructured":"Schetinger MRC, Morsch VM, Bonan CD, Wyse ATS (2007) NTPDase and 5\u2019-nucleotidase activities in physiological and disease conditions: new perspectives for human health. BioFactors 31:77\u201398. https:\/\/doi.org\/10.1002\/biof.5520310205","journal-title":"BioFactors"},{"key":"10121_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1183793","volume":"11","author":"D Forstner","year":"2023","unstructured":"Forstner D, Guettler J, Brugger BA et al (2023) CD39 abrogates platelet-derived factors induced IL-1\u03b2 expression in the human placenta. Front Cell Dev Biol 11:1183793. https:\/\/doi.org\/10.3389\/fcell.2023.1183793","journal-title":"Front Cell Dev Biol"},{"key":"10121_CR58","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.239939","volume":"133","author":"M Basu","year":"2020","unstructured":"Basu M, Gupta P, Dutta A et al (2020) Increased host ATP efflux and its conversion to extracellular adenosine is crucial for establishing Leishmania infection. J Cell Sci 133:jcs239939. https:\/\/doi.org\/10.1242\/jcs.239939","journal-title":"J Cell Sci"},{"key":"10121_CR59","doi-asserted-by":"publisher","first-page":"10453","DOI":"10.2147\/OTT.S272553","volume":"13","author":"J Wu","year":"2020","unstructured":"Wu J, Wang Y-C, Xu W-H et al (2020) High expression of CD39 is associated with poor prognosis and immune infiltrates in clear cell renal cell carcinoma. Onco Targets Ther 13:10453\u201310464. https:\/\/doi.org\/10.2147\/OTT.S272553","journal-title":"Onco Targets Ther"},{"key":"10121_CR60","doi-asserted-by":"publisher","first-page":"9411","DOI":"10.1007\/s13277-015-3683-9","volume":"36","author":"B Zhang","year":"2015","unstructured":"Zhang B, Cheng B, Li F-S et al (2015) High expression of CD39\/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma. Tumour Biol 36:9411\u20139419. https:\/\/doi.org\/10.1007\/s13277-015-3683-9","journal-title":"Tumour Biol"},{"key":"10121_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Pacher P, Vizi ES, Hask\u00f3 G (2013) CD39 and CD73 in immunity and inflammation. Trends Mol Med 19:355\u2013367. https:\/\/doi.org\/10.1016\/j.molmed.2013.03.005","journal-title":"Trends Mol Med"},{"key":"10121_CR62","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1111\/jth.15820","volume":"20","author":"L Zheng","year":"2022","unstructured":"Zheng L, Cao L, Zheng XL (2022) ADAMTS13 protease or lack of von Willebrand factor protects irradiation and melanoma-induced thrombotic microangiopathy in zebrafish. J Thromb Haemost 20:2270\u20132283. https:\/\/doi.org\/10.1111\/jth.15820","journal-title":"J Thromb Haemost"},{"key":"10121_CR63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11302-019-09686-x","volume":"16","author":"JB Willig","year":"2020","unstructured":"Willig JB, Vianna DRB, Beckenkamp A et al (2020) Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line. Purinergic Signal 16:29\u201340. https:\/\/doi.org\/10.1007\/s11302-019-09686-x","journal-title":"Purinergic Signal"},{"key":"10121_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158068","volume":"22","author":"E Timperi","year":"2021","unstructured":"Timperi E, Barnaba V (2021) CD39 regulation and functions in T cells. Int J Mol Sci 22:8068. https:\/\/doi.org\/10.3390\/ijms22158068","journal-title":"Int J Mol Sci"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-025-10121-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10121-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:06:58Z","timestamp":1771884418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-025-10121-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10121"],"URL":"https:\/\/doi.org\/10.1007\/s11302-025-10121-7","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and all described methods and protocols were approved by the Ethics Committee of the Federal University of Fronteira Sul (UFFS), registration number (CAAE: 42603621.20000.5564). Each participant has read and signed the Consent to Participate Declaration before the beginning of the experimental protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}